Jim Cramer Says Moderna, Inc. (MRNA)’s Vaccine Pipeline and …
WEB1 day ago · Jim Cramer reported that Moderna Inc. (NASDAQ:MRNA)’s shares fell by 10% after the company announced it would cut costs by $1.1 billion. Along with this, Moderna Inc. (NASDAQ:MRNA) revealed ...
Moderna CEO Stephane Bancel sits down one-on-one with Jim Cramer
WEBApr 21, 2023 · Stephane Bancel, CEO of Moderna, joins "Mad Money" host Jim Cramer to discuss the company's goals to expand vaccine production for multiple illnesses.
Jim Cramer on Moderna shares down: Investors should look at Moderna …
WEBNov 4, 2021 · CNBC's Jim Cramer and the 'Squawk on the Street' team react to news from Moderna, which cut its Covid-19 vaccine outlook for the rest of the year due to production issues.
Jim Cramer: Moderna could have been more transparent about ... - YouTube
WEBCNBC's David Faber, Meg Tirrell and Jim Cramer discuss Moderna's recent stock sale after the company released early-stage results of its phase 1 Covid-19 vac...
Cramer thinks investors should look at Moderna ‘a little more ... - CNBC
WEBNov 4, 2021 · CNBC's Jim Cramer and the 'Squawk on the Street' team react to news from Moderna, which cut its Covid-19 vaccine outlook for the rest of the year due to production issues.
Cramer’s lightning round: I am OK with Moderna - CNBC
WEBAug 12, 2021 · It’s that time again! “Mad Money” host Jim Cramer rings the lightning round bell, which means he’s giving his answers to callers’ stock questions at rapid speed. Karyopharm Therapeutics ...
Moderna Vaccine Rally: Jim Cramer's Biggest Worry - TheStreet
WEBNov 16, 2020 · Biggest Shopping Days of the Year in the U.S. Jim Cramer breaks down what vaccine news out of Moderna means for Wall Street and what he's watching going forward.
Moderna Extends Gains as Jim Cramer Talks of Cancer Vaccine - TheStreet
WEBModerna shares jumped higher Friday after Jim Cramer said the drugmaker is nearing the development of a vaccine that could protect against certain forms of cancer.
Cramer's Advice To Moderna: Silence Is Golden - Yahoo Finance
WEBJul 27, 2020 · Drug maker Moderna Inc (NASDAQ: MRNA) is starting a Phase 3 trial of its coronavirus vaccine, and CNBC's Jim Cramer has some advice for the company and its management team.
Moderna stock gains as Jim Cramer says company is working on cancer ...
WEBFeb 26, 2021 · Moderna (NASDAQ:MRNA) shares gained 5% after CNBC's Jim Cramer claimed that the company is working on potential candidates for a cancer vaccine that appears to work. Cramer cited two...
- Some results have been removed
Skip to content